Abstract
Non-activated (electron-rich and/or sterically hindered) arenes are prevalent chemical scaffolds in pharmaceuticals and positron emission tomography (PET) diagnostics. Despite substantial efforts to develop a general method to introduce 18F into these moieties for molecular imaging by PET, there is an urgent and unmet need for novel radiofluorination strategies that result in sufficiently labeled tracers to enable human imaging. Herein, we describe an efficient method that relies on spirocyclic iodonium ylide (SCIDY) precursors for one-step and regioselective radiofluorination, as well as proof-of-concept translation to the radiosynthesis of a clinically useful PET tracer, 3-[18F]fluoro-5-[(pyridin-3-yl)ethynyl] benzonitrile ([18F]FPEB). The protocol begins with the preparation of a SCIDY precursor for FPEB, followed by radiosynthesis of [18F]FPEB, by either manual operation or an automated synthesis module. [18F]FPEB can be obtained in quantities >7.4 GBq (200 mCi), ready for injection (20 ± 5%, non–decay corrected), and has excellent chemical and radiochemical purity (>98%) as well as high molar activity (666 ± 51.8 GBq/μmol; 18 ± 1.4 Ci/μmol). The total time for the synthesis and purification of the corresponding labeling SCIDY precursor is 10 h. The subsequent radionuclide production, experimental setup, 18F labeling, and formulation of a product that is ready for injection require 2 h.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ametamey, S. M., Honer, M. & Schubiger, P. A. Molecular imaging with PET. Chem. Rev. 108, 1501–1516 (2008).
Miller, P. W., Long, N. J., Vilar, R. & Gee, A. D. Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography. Angew. Chem. Int. Ed. Engl. 47, 8998–9033 (2008).
Phelps, M. E. Positron emission tomography provides molecular imaging of biological processes. Proc. Natl. Acad. Sci. USA 97, 9226–9233 (2000).
Brooks, A. F., Topczewski, J. J., Ichiishi, N., Sanford, M. S. & Scott, P. J. Late-stage [18F]fluorination: new solutions to old problems. Chem. Sci. 5, 4545–4553 (2014).
Cole, E. L., Stewart, M. N., Littich, R., Hoareau, R. & Scott, P. J. Radiosyntheses using fluorine-18: the art and science of late stage fluorination. Curr. Top. Med. Chem. 14, 875–900 (2014).
Campbell, M. G. & Ritter, T. Modern carbon-fluorine bond forming reactions for aryl fluoride synthesis. Chem. Rev. 115, 612–633 (2015).
Liang, S. H. & Vasdev, N. Total radiosynthesis: thinking outside “the box”. Aust. J. Chem. 68, 1319–1328 (2015).
Preshlock, S., Tredwell, M. & Gouverneur, V. 18F-labeling of arenes and heteroarenes for applications in positron emission tomography. Chem. Rev. 116, 719–766 (2016).
Di Raddo, P., Diksic, M. & Jolly, D. The 18F radiofluorination of arylsilanes. J. Chem. Soc. Chem. Commun. 1984, 159–160 (1984).
Chirakal, R., Coates, G., Firnau, G., Schrobilgen, G. J. & Nahmias, C. Direct radiofluorination of dopamine: 18F-labeled 6-fluorodopamine for imaging cardiac sympathetic innervation in humans using positron emission tomography. Nucl. Med. Biol. 23, 41–45 (1996).
Firnau, G., Chirakal, R. & Garnett, E. S. Aromatic radiofluorination with [18F]fluorine gas: 6-[18F]fluoro-l-dopa. J. Nucl. Med. 25, 1228–1233 (1984).
Balz, G. & Schiemann, G. Über aromatische Fluorverbindungen, I.: Ein neues Verfahren zu ihrer Darstellung. Eur. J. Inorg. Chem. 60, 1186–1190 (1927).
Wallach, O. Ueber das verhalten einiger diazo und diazoamidoverbindungen. Eur. J. Org. Chem. 235, 233–255 (1886).
Linjing, M. et al. 18F‐radiolabeling of aromatic compounds using triarylsulfonium salts. Eur. J. Org. Chem. 2012, 889–892 (2012).
Sander, K. et al. Sulfonium salts as leaving groups for aromatic labelling of drug-like small molecules with fluorine-18. Sci. Rep. 5, 9941 (2015).
Chun, J. H., Morse, C. L., Chin, F. T. & Pike, V. W. No-carrier-added [18F]fluoroarenes from the radiofluorination of diaryl sulfoxides. Chem. Commun. 49, 2151–2153 (2013).
Wagner, F. M., Ermert, J. & Coenen, H. H. Three-step, “one-pot” radiosynthesis of 6-fluoro-3,4-dihydroxy-l-phenylalanine by isotopic exchange. J. Nucl. Med. 50, 1724–1729 (2009).
Gao, Z. et al. Metal-free oxidative fluorination of phenols with [18F]fluoride. Angew. Chem. Int. Ed. Engl. 51, 6733–6737 (2012).
Neumann, C. N., Hooker, J. M. & Ritter, T. Corrigendum: Concerted nucleophilic aromatic substitution with 19F−and 18F−. Nature 538, 274 (2016).
Lee, E. et al. A fluoride-derived electrophilic late-stage fluorination reagent for PET imaging. Science 334, 639–642 (2011).
Lee, E., Hooker, J. M. & Ritter, T. Nickel-mediated oxidative fluorination for PET with aqueous [18F] fluoride. J Am Chem Soc 134, 17456–17458 (2012).
Hoover, A. J. et al. A transmetalation reaction enables the synthesis of [18F]5-fluorouracil from [18F]fluoride for human PET imaging. Organometallics 35, 1008–1014 (2016).
Beyzavi, M. H. et al. 18F-deoxyfluorination of phenols via ru pi-complexes. ACS Cent. Sci. 3, 944–948 (2017).
Tredwell, M. et al. A general copper-mediated nucleophilic 18F fluorination of arenes. Angew. Chem. Int. Ed. Engl. 53, 7751–7755 (2014).
Ichiishi, N. et al. Copper-catalyzed [18F]fluorination of (mesityl)(aryl)iodonium salts. Org. Lett. 16, 3224–3227 (2014).
Pike, V. W. & Aigbirhio, F. I. Reactions of cyclotron-produced [18F]fluoride with diaryliodonium salts-a novel single-step route to no-carrier-added [18]fluoroarenes. J. Chem. Soc. Chem. Commun. 1995, 2215–2216 (1995).
Ross, T. L., Ermert, J., Hocke, C. & Coenen, H. H. Nucleophilic 18F-fluorination of heteroaromatic iodonium salts with no-carrier-added [18F]fluoride. J. Am. Chem. Soc. 129, 8018–8025 (2007).
Hu, B. et al. A practical, automated synthesis of meta-[18F]fluorobenzylguanidine for clinical use. ACS Chem. Neurosci. 6, 1870–1879 (2015).
Qin, L. et al. A mild and general one-pot synthesis of densely functionalized diaryliodonium salts. Eur. J. Org. Chem. 2015, 5919–5924 (2015).
Haskali, M. B. et al. An investigation of (diacetoxyiodo)arenes as precursors for preparing no-carrier-added [18F]fluoroarenes from cyclotron-produced [18F]fluoride ion. J. Org. Chem. 81, 297–302 (2016).
Neumann, K. D. et al. Efficient automated syntheses of high specific activity 6-[18F]fluorodopamine using a diaryliodonium salt precursor. J. Labelled Comp. Radiopharm. 59, 30–34 (2016).
Chun, J. H., Lu, S., Lee, Y. S. & Pike, V. W. Fast and high-yield microreactor syntheses of ortho-substituted [18F]fluoroarenes from reactions of [18F]fluoride ion with diaryliodonium salts. J. Org. Chem. 75, 3332–3338 (2010).
Moon, B. S. et al. Facile aromatic radiofluorination of [18F]flumazenil from diaryliodonium salts with evaluation of their stability and selectivity. Org. Biomol. Chem. 9, 8346–8355 (2011).
Kuik, W. J. et al. In vivo biodistribution of no-carrier-added 6-18F-fluoro-3,4-dihydroxy-l-phenylalanine (18F-DOPA), produced by a new nucleophilic substitution approach, compared with carrier-added 18F-DOPA, prepared by conventional electrophilic substitution. J. Nucl. Med. 56, 106–112 (2015).
Wang, B., Cerny, R. L., Uppaluri, S., Kempinger, J. J. & Dimagno, S. G. Fluoride-promoted ligand exchange in diaryliodonium salts. J. Fluor. Chem. 131, 1113–1121 (2010).
Rotstein, B. H., Stephenson, N. A., Vasdev, N. & Liang, S. H. Spirocyclic hypervalent iodine(III)-mediated radiofluorination of non-activated and hindered aromatics. Nat. Commun. 5, 4365 (2014).
Rotstein, B. H. et al. Mechanistic studies and radiofluorination of structurally diverse pharmaceuticals with spirocyclic iodonium(III) ylides. Chem. Sci. 7, 4407–4417 (2016).
Cardinale, J., Ermert, J., Humpert, S. & Coenen, H. H. Iodonium ylides for one-step, no-carrier-added radiofluorination of electron rich arenes, exemplified with 4-(([18F]fluorophenoxy)-phenylmethyl)piperidine NET and SERT ligands. RSC Adv. 4, 17293–17299 (2014).
Kugler, F., Ermert, J., Kaufholz, P. & Coenen, H. H. 4-[18F]Fluorophenylpiperazines by improved Hartwig–Buchwald N-arylation of 4-[18F]fluoroiodobenzene, formed via hypervalent lambda3-iodane precursors: application to build-up of the dopamine D4 ligand [18F]FAUC 316. Molecules 20, 470–486 (2014).
Nymann, P. I., Langgaard, K. J. & Manfred, H. M. Nucleophilic 18F‐labeling of spirocyclic iodonium ylide or boronic pinacol ester precursors: advantages and disadvantages. Eur. J. Org. Chem. 2017, 453–458 (2017).
Jacobson, O. et al. 18F-labeled single-stranded DNA aptamer for PET imaging of protein tyrosine kinase-7 expression. J. Nucl. Med. 56, 1780–1785 (2015).
Wang, L. et al. Ortho-stabilized 18F-azido click agents and their application in PET imaging with single-stranded DNA aptamers. Angew. Chem. Int. Ed. Engl. 54, 12777–12781 (2015).
Cai, Z. et al. Fluorine-18-labeled antagonist for PET imaging of kappa opioid receptors. ACS Chem. Neurosci. 8, 12–16 (2017).
Wang, L. et al. A facile radiolabeling of [18F]FDPA via spirocyclic iodonium ylides: preliminary PET imaging studies in preclinical models of neuroinflammation. J. Med. Chem. 60, 5222–5227 (2017).
Collier, T. L. et al. Synthesis and preliminary PET imaging of 11C and 18F isotopologues of the ROS1/ALK inhibitor lorlatinib. Nat. Commun. 8, 15761 (2017).
Stephenson, N. A. et al. Iodonium ylide-mediated radiofluorination of 18F-FPEB and validation for human use. J. Nucl. Med. 56, 489–492 (2015).
Murray, R. W. & Singh, M. Synthesis of epoxides using dimethyldioxirane: trans-stilbene oxide. Org. Syn. 74, 91–97 (1997).
Ye, C., Twamley, B. & Shreeve, J. M. Straightforward syntheses of hypervalent iodine(III) reagents mediated by Selectfluor. Org. Lett. 7, 3961–3964 (2005).
Linlin, Q. et al. A mild and general one‐pot synthesis of densely functionalized diaryliodonium salts. Eur. J. Org. Chem. 2015, 5919–5924 (2015).
Niswender, C. M. & Conn, P. J. Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu. Rev. Pharmacol. Toxicol. 50, 295–322 (2010).
Hamill, T. G. et al. Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers. Synapse 56, 205–216 (2005).
Wang, J. Q., Tueckmantel, W., Zhu, A., Pellegrino, D. & Brownell, A. L. Synthesis and preliminary biological evaluation of 3-[18F]fluoro-5-(2-pyridinylethynyl)benzonitrile as a PET radiotracer for imaging metabotropic glutamate receptor subtype 5. Synapse 61, 951–961 (2007).
Lim, K., Labaree, D., Li, S. & Huang, Y. Preparation of the metabotropic glutamate receptor 5 (mGluR5) PET tracer [18F]FPEB for human use: an automated radiosynthesis and a novel one-pot synthesis of its radiolabeling precursor. Appl. Radiat. Isot. 94, 349–354 (2014).
Liang, S. H. et al. Microfluidic continuous-flow radiosynthesis of [18F]FPEB suitable for human PET imaging. Medchemcomm 5, 432–435 (2014).
Mossine, A. V. et al. Synthesis of [18F]arenes via the copper-mediated [18F]fluorination of boronic acids. Org. Lett. 17, 5780–5783 (2015).
Preshlock, S. et al. Enhanced copper-mediated 18F-fluorination of aryl boronic esters provides eight radiotracers for PET applications. Chem. Commun. 52, 8361–8364 (2016).
Makaravage, K. J., Brooks, A. F., Mossine, A. V., Sanford, M. S. & Scott, P. J. Copper-mediated radiofluorination of arylstannanes with [18F]KF. Org. Lett. 18, 5440–5443 (2016).
Alagille, D. et al. Potent mGluR5 antagonists: pyridyl and thiazolyl-ethynyl-3,5-disubstituted-phenyl series. Bioorg. Med. Chem. Lett. 21, 3243–3247 (2011).
Schlyer, D. J., Firouzbakht, M. L. & Wolf, A. P. Impurities in the [18O]water target and their effect on the yield of an aromatic displacement reaction with [18F]fluoride. Appl. Radiat. Isot. 44, 1459–1465 (1993).
Acknowledgements
We thank X. Zhang and Z. Chen for technical support and members of the staff in the radiochemistry and radiopharmaceutical development program at MGH for helpful discussions.
Author information
Authors and Affiliations
Contributions
S.H.L., L.W., N.A.S., and B.H.R. performed the experimental work. S.H.L. and N.V. oversaw the radiopharmaceutical production. All authors wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Related links
Key references using this protocol
Rotstein, B.H., Stephenson, N.A., Vasdev, N. & Liang, S.H. Nat. Commun. 5, 4365 (2014): https://www.nature.com/articles/ncomms5365
Rotstein, B.H. et al. Chem. Sci. 7, 4407–4417 (2016): https://pubs.rsc.org/en/content/articlelanding/2016/sc/c6sc00197a#!divAbstract
Stephenson, N.A. et al. J. Nucl. Med. 56, 489–492 (2015): http://jnm.snmjournals.org/content/56/3/489.long
Wang, L. et al. J. Med. Chem. 60, 5222–5227 (2017): https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00432
Key data used in this protocol
Rotstein, B.H., Stephenson, N.A., Vasdev, N. & Liang, S.H. Nat. Commun. 5, 4365 (2014): https://www.nature.com/articles/ncomms5365
Stephenson, N.A. et al. J. Nucl. Med. 56, 489–492 (2015): http://jnm.snmjournals.org/content/56/3/489.long
Supplementary information
Rights and permissions
About this article
Cite this article
Liang, S.H., Wang, L., Stephenson, N.A. et al. Facile 18F labeling of non-activated arenes via a spirocyclic iodonium(III) ylide method and its application in the synthesis of the mGluR5 PET radiopharmaceutical [18F]FPEB. Nat Protoc 14, 1530–1545 (2019). https://doi.org/10.1038/s41596-019-0149-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41596-019-0149-3
This article is cited by
-
State of the art procedures towards reactive [18F]fluoride in PET tracer synthesis
EJNMMI Radiopharmacy and Chemistry (2023)
-
Radiochemistry for positron emission tomography
Nature Communications (2023)
-
Arene radiofluorination enabled by photoredox-mediated halide interconversion
Nature Chemistry (2022)
-
Closing the gap between 19F and 18F chemistry
EJNMMI Radiopharmacy and Chemistry (2021)
-
Synthesis of high-molar-activity [18F]6-fluoro-l-DOPA suitable for human use via Cu-mediated fluorination of a BPin precursor
Nature Protocols (2020)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.